Book 2017

Pharmacovigilance

Critique and Ways Forward

Editors:

ISBN: 978-3-319-40399-1 (Print) 978-3-319-40400-4 (Online)

Table of contents (18 chapters)

  1. Front Matter

    Pages i-xxxi

  2. No Access

    Chapter

    Pages 1-8

    Teaching Pharmacovigilance in University

  3. No Access

    Chapter

    Pages 9-19

    Lost in Regulation

  4. No Access

    Chapter

    Pages 21-30

    What Is the Future of Pharmacovigilance and How Can We Make It as Good as Possible?

  5. No Access

    Chapter

    Pages 31-33

    Some Other Ideas About the Future of Pharmacovigilance

  6. No Access

    Chapter

    Pages 35-48

    Best Safety Practices Now and in the Future

  7. No Access

    Chapter

    Pages 49-53

    Is There a Benefit from the Medical Literature Monitoring Service of the EMA?

  8. No Access

    Chapter

    Pages 55-66

    The Unified Drug Safety-Clinical Database

  9. No Access

    Chapter

    Pages 67-79

    Behind the Scenes: ‘Silent Factors’ Influencing Pharmacovigilance Practice and Decisions

  10. No Access

    Chapter

    Pages 81-97

    Shaking Up Culture and Communication in PV [V6]

  11. No Access

    Chapter

    Pages 99-114

    Pharmacovigilance Indicators: Desiderata for the Future of Medicine Safety

  12. No Access

    Chapter

    Pages 115-120

    Thoughts on Pharmacovigilance in the Future: There Are More Weber-Effects

  13. No Access

    Chapter

    Pages 121-130

    Effective Treatment Matters: Revitalizing Pharmacovigilance

  14. No Access

    Chapter

    Pages 131-144

    Broadening the Scope of Pharmacovigilance

  15. No Access

    Chapter

    Pages 145-159

    Herbal and Traditional Medicines, Now and Future

  16. No Access

    Chapter

    Pages 161-172

    The Concept of ‘Health’

  17. No Access

    Chapter

    Pages 173-179

    Impact of Referral Procedures on the Interaction of RMP and PSUR

  18. No Access

    Chapter

    Pages 181-193

    Other Sources of Information for Monitoring Drug Safety: Now and in the Future

  19. No Access

    Chapter

    Pages 195-205

    Ecopharmacovigilance